In a clinical cohort of 263 pairs of CRC tumors and adjacent noncancerous tissues, researchers found a significantly higher abundance of Fusobacterium nucleatum in KRAS‐mutated tissues compared to both adjacent tissues and KRAS wild‐type tissues. This evidence concerns the gene KRAS and colorectal carcinoma.